Stemtech (STEK) Other Working Capital Changes (2013 - 2025)
Stemtech's (STEK) quarterly Other Working Capital Changes came in at -$203388.0 in Q4 2025, down 1874.07% year-on-year from $11464.5 in Q4 2024, and down 5586.59% quarter-over-quarter from $3707.0 in Q3 2025.
Stemtech (STEK) Other Working Capital Changes (2013 - 2025) Analysis & Trends
Stemtech has disclosed Other Working Capital Changes across 12 years of filings, most recently posting -$203388.0 for Q4 2025.
- Other Working Capital Changes for Q4 2025 came in at -$203388.0, down 1874.07% year-over-year; the trailing twelve-month figure through Dec 2025 was -$197865.0 (down 262.55% YoY), and the FY2025 annual result was -$197865.0, down 262.55% from the prior year.
- Other Working Capital Changes came in at -$203388.0 for Q4 2025 at Stemtech, down from $3707.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $68866.0 in Q2 2021 to a low of -$203388.0 in Q4 2025.
- The 5-year median for Other Working Capital Changes is -$1203.0 (2023), against an average of -$19166.2.
- Across the five-year window, Other Working Capital Changes soared 2290.61% in 2024 and sank 1874.07% in 2025, its largest moves.
- Stemtech's Other Working Capital Changes stood at -$93908.0 in 2021, then surged by 142.45% to $39862.0 in 2022, then sank by 230.55% to -$52041.0 in 2023, then soared by 80.2% to -$10303.0 in 2024, then tumbled by 1874.07% to -$203388.0 in 2025.
- The last three Other Working Capital Changes figures came in at -$203388.0 (Q4 2025), $3707.0 (Q3 2025), and -$3499.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Stemtech | - | - | 354,677.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -203,388.00 |
| Dec 31, 2025 | -203,388.00 |
| Sep 30, 2025 | 3,707.00 |
| Sep 30, 2025 | 3,707.00 |
| Jun 30, 2025 | -3,499.00 |
| Jun 30, 2025 | -3,499.00 |
| Mar 31, 2025 | 5,315.00 |
| Mar 31, 2025 | 5,315.00 |
| Dec 31, 2024 | -10,303.00 |
| Dec 31, 2024 | -10,303.00 |
| Sep 30, 2024 | 62,094.00 |
| Sep 30, 2024 | 62,094.00 |
| Jun 30, 2024 | -132,720.00 |
| Jun 30, 2024 | -132,720.00 |
| Mar 31, 2024 | 26,353.00 |
| Mar 31, 2024 | 26,353.00 |
| Dec 31, 2023 | -52,041.00 |
| Dec 31, 2023 | -52,041.00 |
| Sep 30, 2023 | -71,993.00 |
| Sep 30, 2023 | -71,993.00 |